Vimta Labs Ltd Share Price & Stock Analysis

Vimta Labs Ltd (BSE: 524394) is a Hyderabad, Telangana-based company in the Life Sciences Tools and Services industry. With a market capitalisation of ₹2,259 Cr, it ranks #1,188 by market cap among the 6,197 Indian listed companies on FinBizNet, and #3 of 10 in Life Sciences Tools and Services. At ₹471.60 (as of 19 Nov 2026), the share price is 30.1% below its 52-week high of ₹675.00 and 25.4% above its 52-week low of ₹376.05. The share price is down 26.8% over one year and down 24.3% over three months.

Key Metrics

Current Price₹471.60
Market Cap₹2,259 Cr
BSE Code524394
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services
Sub-IndustryLife Sciences Tools and Services
P/E Ratio29.5
Return on Equity18.55%
Return on Assets12.19%
52-Week Range₹376.05 – ₹675.00
1-Year Price Change-26.8%
3-Month Price Change-24.3%
Beta (1Y)0.67
Dividend Yield0.39%
HeadquartersHyderabad, Telangana
Websitevimta.com

Latest Quarterly Results — Q2 FY27

Revenue₹112 Cr
Net Profit₹21 Cr
Net Margin18.4%
EPS (Basic)₹4.61
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Vimta Labs Ltd Quarterly Revenue and Profit Trend

Vimta Labs Ltd reported revenue of ₹112 Cr in Q2 FY27, up 9.9% from ₹102 Cr in Q2 FY26 and up 2.7% from ₹109 Cr in Q1 FY27. It posted a net profit of ₹21 Cr for the quarter, against a net profit of ₹20 Cr in Q2 FY26 (up 3.5%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹94 Cr (Q4 FY25) to ₹112 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹112 Cr₹21 Cr18.4%
Q1 FY27₹109 Cr₹21 Cr19.3%
Q4 FY26₹109 Cr₹21 Cr19.3%
Q3 FY26₹99 Cr₹18 Cr17.8%
Q2 FY26₹102 Cr₹20 Cr19.6%
Q1 FY26₹98 Cr₹19 Cr19.4%
Q4 FY25₹94 Cr₹18 Cr19.4%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 35.64% of Vimta Labs Ltd's shares as of Sept 2026, against 35.99% in Sept 2025 (−0.35 percentage points). Delivery averaged 43.5% of traded volume across 18 NSE sessions (26 Oct 2026 – 19 Nov 2026).

About Vimta Labs Ltd

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides

Products and Services

1. Contract Research and Testing Services-This segment provides contract research and testing services.

Business Segments

1. Contract Research and Testing Services-100%

Vimta Labs Ltd vs Peers — Life Sciences Tools and Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Indegene Ltd₹14,840 Cr40.213.94%₹1,122 Cr+26.1%
Suven Life Sciences Ltd.₹7,951 Crn/m-78.80%₹1 Cr+51.8%
Vimta Labs Ltd₹2,259 Cr29.518.55%₹112 Cr-26.8%
Tarsons Products Limited₹1,730 Cr114.92.26%₹124 Cr+25.7%
Brooks Laboratories Ltd.₹198 Cr7.922.28%₹19 Cr-34.2%
Bilcare Ltd.₹194 Cr108.3-5.21%——
Jeevan Scientific Technology Ltd₹176 Cr129.41.68%—+42.3%
Vivo Bio Tech Ltd.₹37 Crn/m-2.00%₹14 Cr-55.7%
Dr. Habeebbullal Life Sciences Ltd₹26 Crn/m-68.79%—-45.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Vimta Labs Ltd?

Vimta Labs Ltd is trading at ₹471.60, with a market capitalisation of ₹2,259 Cr.

Which sector does Vimta Labs Ltd belong to?

Vimta Labs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).

What are the key financial ratios of Vimta Labs Ltd?

Vimta Labs Ltd has a P/E of 29.5 and a return on equity of 18.55%.

What is the stock symbol of Vimta Labs Ltd?

Vimta Labs Ltd is listed on the BSE under the scrip code 524394.

How has Vimta Labs Ltd's share price moved over the past year?

Vimta Labs Ltd's share price is down 26.8% over one year and down 24.3% over three months. Its 52-week range is ₹376.05 to ₹675.00.

What were Vimta Labs Ltd's latest quarterly results?

In Q2 FY27, Vimta Labs Ltd reported revenue of ₹112 Cr and net profit of ₹21 Cr, with basic EPS of ₹4.61 (standalone, parsed from the company's exchange filing).

How have Vimta Labs Ltd's revenue and profit changed over the past year?

Vimta Labs Ltd reported revenue of ₹112 Cr in Q2 FY27, up 9.9% from ₹102 Cr in Q2 FY26 and up 2.7% from ₹109 Cr in Q1 FY27.

What is the promoter holding in Vimta Labs Ltd?

Promoters held 35.64% of Vimta Labs Ltd's shares as of Sept 2026, against 35.99% in Sept 2025 (−0.35 percentage points).

More on FinBizNet

Data as of 19 Nov 2026. Descriptive market data only — not investment advice.